Cargando…

Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment

It is estimated that one third of the world’s population is infected with Mycobacterium tuberculosis (Mtb). This astounding statistic, in combination with costly and lengthy treatment regimens make the development of therapeutic vaccines paramount for controlling the global burden of tuberculosis. U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larsen, Sasha E., Baldwin, Susan L., Orr, Mark T., Reese, Valerie A., Pecor, Tiffany, Granger, Brian, Dubois Cauwelaert, Natasha, Podell, Brendan K., Coler, Rhea N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027321/ https://www.ncbi.nlm.nih.gov/pubmed/29795025 http://dx.doi.org/10.3390/vaccines6020030

Ejemplares similares

Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations
por: Baldwin, Susan L., et al.
Publicado: (2022)

Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models
por: Larsen, Sasha E., et al.
Publicado: (2021)

Characterizing in vivo loss of virulence of an HN878 Mycobacterium tuberculosis isolate from a genetic duplication event
por: Berube, Bryan J., et al.
Publicado: (2022)

An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis
por: Larsen, Sasha E., et al.
Publicado: (2023)

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model
por: Baldwin, Susan L., et al.
Publicado: (2021)

Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis?
por: Larsen, Sasha E., et al.
Publicado: (2023)

It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity
por: Larsen, Sasha E., et al.
Publicado: (2022)

The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for T(H)1 Induction
por: Cauwelaert, Natasha Dubois, et al.
Publicado: (2016)

Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model
por: Kwon, Kee Woong, et al.
Publicado: (2019)

The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases
por: Baldwin, Susan L., et al.
Publicado: (2019)

Mycobacterium abscessus: It’s Complex
por: Abdelaal, Hazem F. M., et al.
Publicado: (2022)

Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
por: Larsen, Sasha E., et al.
Publicado: (2021)

Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
por: Larsen, Sasha E., et al.
Publicado: (2021)

Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
por: Kiran, Dilara, et al.
Publicado: (2015)

Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection
por: Baldwin, Susan L., et al.
Publicado: (2018)

Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration
por: Maloney, Sara E., et al.
Publicado: (2023)

Abstract 1647: Quantification of functional antibody titers in a mouse model of SARS-CoV-2 infection
por: Hernandez, Dulce, et al.
Publicado: (2023)

Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination
por: Armistead, Blair, et al.
Publicado: (2022)

Non-Diabetic Hyperglycemia Exacerbates Disease Severity in Mycobacterium tuberculosis Infected Guinea Pigs
por: Podell, Brendan K., et al.
Publicado: (2012)

Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
por: Choi, Yu Hwa, et al.
Publicado: (2023)

Editorial: Beyond Th1: Novel concepts in tuberculosis vaccine immunology
por: Dijkman, Karin, et al.
Publicado: (2022)

Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination
por: Armistead, Blair, et al.
Publicado: (2023)

The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis
por: Henao-Tamayo, Marcela, et al.
Publicado: (2015)

Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection
por: Tian, Wei-wei, et al.
Publicado: (2013)

Expression Cloning of an Immunodominant Family of Mycobacterium tuberculosis Antigens Using Human Cd4(+) T Cells
por: Alderson, Mark R., et al.
Publicado: (2000)

SARS-CoV-2 infection and immune responses
por: Harne, Rakhi, et al.
Publicado: (2023)

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE
por: Coler, Rhea N, et al.
Publicado: (2015)

Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach
por: Kramer, Ryan M, et al.
Publicado: (2018)

Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis
por: Frenkel, Jessica D. Haugen, et al.
Publicado: (2020)

A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93
por: Orr, Mark T., et al.
Publicado: (2014)

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses
por: Walter, Nicholas D., et al.
Publicado: (2023)

Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

Mycobacterium tuberculosis and the host response
por: Kaufmann, Stefan H.E., et al.
Publicado: (2005)

Mycobacterium tuberculosis Alters the Metalloprotease Activity of the COP9 Signalosome
por: Danelishvili, Lia, et al.
Publicado: (2014)

DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in Mycobacterium tuberculosis
por: Chengalroyen, Melissa D., et al.
Publicado: (2022)

Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients
Publicado: (1983)

Death of Mycobacterium tuberculosis by l-arginine starvation
por: Mizrahi, Valerie, et al.
Publicado: (2018)

Development of multidrug-resistant Mycobacterium tuberculosis in the biofilm of a peritoneal-venous shunt
por: Redman, Romany M., et al.
Publicado: (2023)

Mycobacterium tuberculosis pili (MTP), a putative biomarker for a tuberculosis diagnostic test
por: Naidoo, Natasha, et al.
Publicado: (2014)

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy
por: Fox, Christopher B., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_olar3082hm1rh24ddns2on4rmn